EyeTechCare, a France-based company developing medical devices for eyes, has raised €10m ($13m) in its series C round from a consortium including local insurer Sham. The other investors included venture capital firm Omnes Capital, which was formerly known Credit Agricole Private Equity (Cape) until it spun off from the eponymous bank, and angel investor Bernard Chauvin. The money will fund a clinical trial of its EyeOP1 ultrasound glaucoma treatment. In July 2010, EyeTechCare raised €7.5m in its B round, with Sham investing €3m and Cape the remainder. Two years earlier, in July 2008, the company raised €1.2m from Cape and CEA-Investissement.

Subscribe to go deeper

GCV subscribers get access to all our proprietary data and deep-dive articles, as well as the global directory of CVC investors.



Not sure if you have a subscription?